Law360 discusses a New Jersey federal court class action challenging AMAG Inc.’s marketing and sale of a drug advertised as reducing the chance of preterm births. A New Jersey federal judge dismissed the case without prejudice. David Kott defended AMAG in the matter.
5.25.2021